NCT05641896 Study of [18F]FAPI-74 PET in Patients With Gastrointestinal Cancers Status COMPLETED Phase PHASE2
NCT05634694 Study on Consistency Evaluation for Drug Sensitivity of Patient-Derived Organoid Model From Cholangiocarcinoma Patients Status UNKNOWN Phase N/A
NCT05600803 Screening Single-operator Cholangioscopy for Neoplastic Bile Duct Lesions Status RECRUITING Phase N/A
NCT05596370 Association Between Cell-free Nucleic Acid in Blood, Urine and Microbiome in Stool With Pancreatobiliary Cancer Status UNKNOWN Phase N/A
NCT05580328 An Exploratory Clinical Study of Photodynamic Therapy Combined With Sonodynamic Therapy in Cholangiocarcinoma Status UNKNOWN Phase NA
NCT05563272 89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors Status TERMINATED Phase PHASE2
NCT05519605 Bile Duct Drainage After ERCP Failure: EUS-BD vs PTBD Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05518071 FLUOPANC-trial - Fluorescence-guided Surgery of Pancreatic and Bileduct Tumors Using cRGD-ZW800-1 Status COMPLETED Phase PHASE2
NCT05510427 Phase Ib Trial of Infigratinib In Combination With Atezolizumab And Bevacizumab for The Second-Line Treatment of Advanced Cholangiocarcinoma With FGFR2 Fusion/Amplification Status WITHDRAWN Phase PHASE1
NCT05506943 A Study of CTX-009 in Combination With Paclitaxel in Adult Patients With Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers (COMPANION-002) Status ACTIVE_NOT_RECRUITING Phase PHASE2/PHASE3
NCT05497531 Pilot Comparing ctDNA IDV vs. SPV Sample in Pts Undergoing Biopsies for Hepatobiliary and Pancreatic Cancers Status RECRUITING Phase NA
NCT05461430 Mass Response of Tumor Cells as a Biomarker for Rapid Therapy Guidance (TraveraRTGx) Status COMPLETED Phase N/A
NCT05451849 A Phase 1/2 Trial of TC-510 In Patients With Advanced Mesothelin-Expressing Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT05451043 Durvalumab and Tremelimumab in Combination With Propranolol and Chemotherapy for Treatment of Advanced Hepatopancreabiliary Tumors (BLOCKED) Status RECRUITING Phase PHASE2
NCT05432193 FAPi Radioligand OpeN-Label, Phase 1 Study to Evaluate Safety, Tolerability and DosImetry of [Lu-177]-PNT6555; A Dose Escalation Study for TReatment of Patients With Select Solid Tumors (FRONTIER) Status TERMINATED Phase PHASE1
NCT05411133 Treatment of Cabotamig (ARB202) in Advanced Gastrointestinal Cancer Patients Status COMPLETED Phase PHASE1